Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.verified

PSTX

Price:

$9.5

Market Cap:

$925.93M

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD...[Read more]

Industry

Biotechnology

IPO Date

2020-07-10

Stock Exchange

NASDAQ

Ticker

PSTX

The ROE as of November 2025 (TTM) for Poseida Therapeutics, Inc. (PSTX) is -15.05%

According to Poseida Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -15.05%. This represents a change of -24.97% compared to the average of -20.05% of the last 4 quarters.

Poseida Therapeutics, Inc. (PSTX) Historical ROE (quarterly & annually)

How has PSTX ROE performed in the past?

The mean historical ROE of Poseida Therapeutics, Inc. over the last ten years is 0.15%. The current -15.05% ROE has changed -10097.49% with respect to the historical average. Over the past ten years (40 quarters), PSTX's ROE was at its highest in in the March 2019 quarter at 499.96%. The ROE was at its lowest in in the June 2022 quarter at -67.67%.

Quarterly (TTM)
Annual

Average

0.15%

Median

1.88%

Minimum

-119.02%

Maximum

61.96%

Poseida Therapeutics, Inc. (PSTX) ROE by Quarter and Year

Discovering the peaks and valleys of Poseida Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 248.87%

Maximum Annual ROE = 61.96%

Minimum Annual Increase = -1310.18%

Minimum Annual ROE = -119.02%

Quarterly (TTM)
Annual
YearROEChange
2023-119.02%248.87%
2022-34.12%-1310.18%
20212.82%201.14%
20200.94%-98.49%
201961.96%7.05%
201857.88%-1.26%
201758.62%-310.35%

Poseida Therapeutics, Inc. (PSTX) Average ROE

How has PSTX ROE performed in the past?

The current ROE of Poseida Therapeutics, Inc. (PSTX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-50.11%

5-year avg

-17.49%

10-year avg

0.15%

Poseida Therapeutics, Inc. (PSTX) ROE vs. Peers

How is PSTX’s ROE compared to its peers?

Poseida Therapeutics, Inc.’s ROE is greater than Gracell Biotechnologies Inc. (-37.93%), greater than Harpoon Therapeutics, Inc. (-211.56%), greater than Albireo Pharma, Inc. (-84.83%), greater than Verve Therapeutics, Inc. (-35.82%), greater than Intercept Pharmaceuticals, Inc. (-253.45%), greater than Crescent Biopharma, Inc. (-84.61%), greater than Chimerix, Inc. (-48.31%), greater than VectivBio Holding AG (-56.92%), greater than Avid Bioservices, Inc. (-44.35%), greater than Icosavax, Inc. (-35.64%),

Build a custom stock screener for Poseida Therapeutics, Inc. (PSTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poseida Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Poseida Therapeutics, Inc. (PSTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Poseida Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Poseida Therapeutics, Inc.'s ROE?

How is the ROE calculated for Poseida Therapeutics, Inc. (PSTX)?

What is the highest ROE for Poseida Therapeutics, Inc. (PSTX)?

What is the 3-year average ROE for Poseida Therapeutics, Inc. (PSTX)?

What is the 5-year average ROE for Poseida Therapeutics, Inc. (PSTX)?

How does the current ROE for Poseida Therapeutics, Inc. (PSTX) compare to its historical average?